AVBP
ArriVent BioPharma, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$31.09
+0.19%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.42x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 0.94x
Liquidity & coverage
- Current ratio
- 14.16x
- Quick ratio
- 14.16x
- Cash ratio
- 13.40x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $366.3M
Cash & dividend
- FCF / debt
- -421.45x
- Cash flow / debt
- -421.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026